Jun Shen

557 total citations
30 papers, 327 citations indexed

About

Jun Shen is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Jun Shen has authored 30 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 13 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Jun Shen's work include RNA modifications and cancer (5 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Jun Shen is often cited by papers focused on RNA modifications and cancer (5 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Jun Shen collaborates with scholars based in China, United States and Switzerland. Jun Shen's co-authors include Fei Tong, Yiming Zhong, Hangyu Wu, Yisheng Zhang, Ye Mei, Shizhong Bu, Yingchao Zhu, Yan Liu, Siyang Wu and Linbo Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Medicine.

In The Last Decade

Jun Shen

29 papers receiving 321 citations

Peers

Jun Shen
Yibin Lin China
Harish Kumar United Kingdom
Bojin Su China
Zhangzhou Huang China
Minghan Jia China
Nicoletta Provinciali Italy
Pamela Younes United States
Jane Borley United Kingdom
Valentina Doneddu Italy
Jianguo Lai China
Yibin Lin China
Jun Shen
Citations per year, relative to Jun Shen Jun Shen (= 1×) peers Yibin Lin

Countries citing papers authored by Jun Shen

Since Specialization
Citations

This map shows the geographic impact of Jun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Shen more than expected).

Fields of papers citing papers by Jun Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Shen. The network helps show where Jun Shen may publish in the future.

Co-authorship network of co-authors of Jun Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Shen. A scholar is included among the top collaborators of Jun Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Shen. Jun Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ju, Siwei, Yongxia Chen, Jun Shen, et al.. (2025). 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer. Biomarkers in Medicine. 19(9). 317–328. 1 indexed citations
2.
3.
Shen, Jun, et al.. (2024). Adverse event profiles of CDK4/6 inhibitors: data mining and disproportionality analysis of the FDA adverse event reporting system. Therapeutic Advances in Drug Safety. 15. 6 indexed citations
4.
Tong, Fei, Yi Lu, Hongfang Ma, & Jun Shen. (2024). Comparative efficacy and safety of CDK4/6 inhibitors combined with endocrine therapies for HR+/HER2-breast cancer: Systematic review and network meta-analysis. Heliyon. 10(11). e31583–e31583. 5 indexed citations
5.
6.
7.
Hu, Dengdi, Wenying Zhuo, Feiyang Ji, et al.. (2023). Biological differences between normal and cancer-associated fibroblasts in breast cancer. Heliyon. 9(9). e19803–e19803. 4 indexed citations
8.
Xu, Bin, Jianguo Shen, Jun Shen, & Linbo Wang. (2023). Prognostic impact of HER2-low expression in HER2-negative breast cancer under different hormone receptor status. International Journal of Clinical Oncology. 28(4). 543–549. 8 indexed citations
9.
Shen, Lesang, Huanhuan Huang, Zichen Wei, et al.. (2023). Integrated transcriptomics, proteomics, and functional analysis to characterize the tissue‐specific small extracellular vesicle network of breast cancer. SHILAP Revista de lepidopterología. 4(6). e433–e433. 8 indexed citations
10.
11.
Zhong, Yiming, Fei Tong, & Jun Shen. (2022). Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis. BMC Cancer. 22(1). 102–102. 32 indexed citations
12.
Chen, Yongxia, Yunlu Jia, Misha Mao, et al.. (2021). PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer. Journal of Cellular and Molecular Medicine. 25(14). 6948–6962. 20 indexed citations
13.
Wang, Qi, et al.. (2021). CCR7-CCL21 axis promotes the cervical lymph node metastasis of tongue squamous cell carcinoma by up-regulating MUC1. Journal of Cranio-Maxillofacial Surgery. 49(7). 562–569. 10 indexed citations
14.
Wang, Qinchuan, Xiyong Liu, Chen Chen, et al.. (2020). A predictive signature for oxaliplatin and 5-fluorouracil based chemotherapy in locally advanced gastric cancer. Translational Oncology. 14(1). 100901–100901. 10 indexed citations
15.
Wu, Hangyu, Siyang Wu, Yingchao Zhu, et al.. (2019). Hsa_circRNA_0054633 is highly expressed in gestational diabetes mellitus and closely related to glycosylation index. Clinical Epigenetics. 11(1). 22–22. 72 indexed citations
16.
Li, Xiaolei, et al.. (2018). Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer. OncoTargets and Therapy. Volume 11. 677–685. 7 indexed citations
17.
Zhao, Chenguang, Huiru Zou, Jinhui Wang, Jun Shen, & Hao Liu. (2018). A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction. DNA and Cell Biology. 37(11). 888–895. 15 indexed citations
18.
Yang, Shujuan, et al.. (2016). HLA-DRB1 allele polymorphism and nasopharyngeal carcinoma risk: a meta-analysis. European Archives of Oto-Rhino-Laryngology. 274(1). 297–303. 4 indexed citations
19.
Shen, Jun. (2009). Generalized quantum operations and almost sharp quantum effects. 2 indexed citations
20.
Shen, Jun. (2009). Remarks on the sequential effect algebras. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yibin Lin Breakdown of academic impact, for papers by Harish Kumar Breakdown of academic impact, for papers by Bojin Su Breakdown of academic impact, for papers by Zhangzhou Huang Breakdown of academic impact, for papers by Minghan Jia Breakdown of academic impact, for papers by Nicoletta Provinciali Breakdown of academic impact, for papers by Pamela Younes Breakdown of academic impact, for papers by Jane Borley Breakdown of academic impact, for papers by Valentina Doneddu Breakdown of academic impact, for papers by Jianguo Lai
Rankless by CCL
2026